On Thursday, the generic substitute for Copaxone has been approved by the FDA. Copaxone is a drug used for multiple sclerosis. In the last several years, the prices for drugs geared towards multiple sclerosis have tripled, even as more brand-name products appear in the market. A generic option would give a pricing edge, but this depends on the price and date it will go on sale. The price of all drugs drop about 90% when there are multiple generic options; however, since there is only one, the discount will not be as drastic. None of the drugs that treat multiple sclerosis have a generic equivalent. Multiple sclerosis is a nerve condition that causes blurred vision and difficulty walking. Teva manufacturers Copaxone, a brand name, when it usually manufactures generic drugs. Teva has used some aggressive plans to keep their wide consumer base. Teva has called and took their patients out to dinner, created a more concentrated drug to decrease the number of injections per week, and lowered the price. How Copaxone works is not clear; however, it is known that the main drug in there is made up of 4 amino acids. When the generic drug is released, some insurance companies may recommend that the patients try the generic brand before the name brand. Teva currently has a patent on Copaxone until September 1st, but the federal court invalidated it. They took their case to the Supreme Court for reevaluation, and the generic drug will have to wait in accordance to the court's descision or until September. Other companies, such as Myland and Synthon, are trying to get the approval for their generic Copaxone versions.
I think it is great that the first generic drug for multiple sclerosis is almost available to the public. The prices for name-brand drugs are extremely pricey, and I personally always look for a generic brand. Competition will bring an economically beneficial solution for the people who really need the drug. They could the used the money save on other operations or medications.
Original: Link1
Supplemental: Link2
Its always great to see the drug industry make a medication more widely available to a large population of people instead of just a few.
ReplyDelete